-
China tightens drug administration as law takes effect
2019-12-02
China's revised drug administration law, adopted by the top legislature in August, went into effect on Dec 1, as part of the country's efforts to strengthen supervision to ensure drug safety.
-
State councilor stresses improvement in drug supervision work
2019-11-11
State Councilor Wang Yong urged reforms on drug supervision work and innovative practices during his inspection tours to the National Institutes for Food and Drug Control and the Center for Drug Evaluation under the National Medical Products Administration on Nov 8.
-
2019 ISPE-CCFDIE China Conference held in Nanchang
2019-10-17
From October 11 to 13, 2019, the 2019 ISPE-CCFDIE China Conference, jointly organized by China Center for Food and Drug International Exchange (CCFDIE), NMPA Center for Food and Drug Inspection and the International Society for Pharmaceutical Engineering (ISPE), was successfully held in Nanchang.
-
2019 National Safe Medication Month Activity Launched in Beijing
2019-10-17
On Oct 17, 2019, the Launch Ceremony for 2019 National Safe Medication Month Activity and the 4th China Drug Safety Forum hosted by NMPA and jointly undertaken by China Pharmaceutical Association and People's Daily Online (People's Health Section) was held in Beijing.
-
Treatment for Alzheimer's available by end of 2019
2019-11-04
A home-grown drug treating Alzheimer's disease, the first innovative drug in this area in the past 17 years globally, will be available to Chinese patients before the end of this year.
-
NMPA to deepen cooperation with WHO
2019-11-01
Jiao Hong, Commissioner of China’s National Medical Products Administration (NMPA), recently signed a statement of intent with Director-General of the World Health Organization (WHO), Tedros Adhanom Ghebreyesus.
